source
- Cellares signs first Asian manufacturing deal with Taiwan's GenomeFrontier Therapeutics for CAR-T productionCellares announced a new partnership with Taiwanese biotech GenomeFrontier Therapeutics, marking the manufacturer’s first collaboration in Asia. The agreement will see Cellares evaluate and potenti…
- Biotech hedge fund launches North Immunology to develop long-acting antibody for atopic dermatitisSTAT+ hedge fund is creating a new immunology company called North Immunology with the goal of delivering a better, long-acting antibody therapy for atopic dermatitis. The concept originated two y…